Moreover, BaP metabolite BPDE could induce DNMT3a binding to the promoters of related tumor suppressor genes, which resulted in the aberrant methylation of retinoic acid receptor-β2 (RAR-β2) in human esophageal cancer cells, and BPDE reduced DNMT3b expression [153]. This evidence concerns the gene DNMT3A and esophageal cancer.